Pew Latin American Fellow Profiled in Nature

Pew Latin American fellow Juan David Ramírez Gonzalez was featured in Nature’s career column, “Turning Point,” in the Oct. 2 issue. In the profile, Ramirez Gonzalez describes how his 2014 Pew award allows him to conduct research on parasitic diseases and will position him to return to Colombia, where such infections are endemic.

As a postdoctoral researcher in the laboratory of Michael Grigg at the National Institute of Allergy and Infectious Diseases, Ramírez Gonzalez is investigating how the exchange of genetic information between two different parasites can precipitate the outbreak of disease.

Ramírez Gonzales told Nature about his youth in Colombia and how it influenced the direction of his research.

“Many people in my family had malaria. One had Chagas’ disease. I became really interested in infectious diseases, particularly those caused by parasites,” he said.

After his postdoctoral training concludes, he intends to return to his country to establish his own molecular parasitology laboratory. Although resources for researchers in Colombia are scarce in comparison with the technology and opportunities available in the U.S., Ramírez Gonzalez says the support he receives from Pew will help him to turn the tide.

“I want to help Colombian science to be better appreciated and to do good work that will help to persuade the government to invest more in science,” he said. “I want to do work that has an impact on the health of my country.”

Learn more about Pew’s biomedical programs.

National Homeownership Month

Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.